Corrigendum to "HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia"

J Oncol. 2020 Sep 4:2020:1834190. doi: 10.1155/2020/1834190. eCollection 2020.

Authors

Aida Vitkevičienė¹, Giedrė Skiauterytė¹, Andrius Žučenka^{2

3}, Mindaugas Stoškus², Eglė Gineikienė², Veronika Borutinskaitė¹, Laimonas Griškevičius^{2

3}, Rūta Navakauskienė¹

Affiliations

¹ Department of Molecular Cell Biology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio Av. 7, LT-01257 Vilnius, Lithuania.
² Hematology, Oncology, and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Santariskiu Str. 2, LT-08661 Vilnius, Lithuania.
³ Institute of Clinical Medicine, Vilnius University, M. K. Ciurlionio Str. 21, LT-03101 Vilnius, Lithuania.

Abstract

[This corrects the article DOI: 10.1155/2019/6179573.].

Copyright © 2020 Aida Vitkevičienė et al.

Publication types

Published Erratum